Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of imsidolimab in Participants with Ichthyosis
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Vanda Pharmaceuticals
NCT05954416 · Inherited Epidermolysis Bullosa, Ichthyosis, and more
NCT06330350 · Quality of Life, Ichthyosis, and more
NCT07050810 · Epidermolysis Bullosa, Ichthyosis, and more
NCT06330324 · Ichthyosis, Palmoplantar Keratoses, and more
NCT05295732 · Ichthyosis
Site 106
Palo Alto, California
Site 104
New Haven, Connecticut
Site 112
Miami, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions